Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) trials recruiting in Oklahoma

Fewer than 3 recruiting trials found.

All Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) trials nationally

Cities in Oklahoma

Recruiting trials in Oklahoma

• A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
  NCT05652686 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Oklahoma: Oklahoma City